WRF
GSK icon

Waddell & Reed Financial’s GSK GSK Stock Holding History

Waddell & Reed Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$54.3M Sell
1,216,636
-861,664
-41% -$39.1M 0.11% 217
2020
Q4 		$95.6M Buy
2,078,300
+169,070
+9% +$7.77M 0.2% 140
2020
Q3 		$89.8M Sell
1,909,230
-177,473
-9% -$8.89M 0.22% 128
2020
Q2 		$106M Sell
2,086,703
-95,387
-4% -$4.89M 0.28% 100
2020
Q1 		$103M Sell
2,182,090
-55,009
-2% -$2.93M 0.34% 81
2019
Q4 		$131M Buy
2,237,099
+731,351
+49% +$40.7M 0.33% 86
2019
Q3 		$80.3M Buy
+1,505,748
New +$77.5M 0.21% 139
2016
Q1 		– Sell
-791,777
Closed -$39.9M – 610
2015
Q4 		$39.9M Sell
791,777
-549,223
-41% -$28M 0.06% 232
2015
Q3 		$64.5M Sell
1,341,000
-189,640
-12% -$9.87M 0.11% 191
2015
Q2 		$79.7M Buy
1,530,640
+65,680
+4% +$3.7M 0.11% 190
2015
Q1 		$84.5M Sell
1,464,960
-3,510,904
-71% -$201M 0.12% 193
2014
Q4 		$266M Buy
4,975,864
+4,252,424
+588% +$238M 0.37% 82
2014
Q3 		$41.6M Sell
723,440
-379,600
-34% -$23.3M 0.06% 240
2014
Q2 		$73.7M Buy
1,103,040
+55,840
+5% +$3.78M 0.11% 195
2014
Q1 		$69.9M Buy
1,047,200
+24,400
+2% +$1.65M 0.11% 192
2013
Q4 		$68.3M Buy
1,022,800
+41,360
+4% +$2.68M 0.11% 194
2013
Q3 		$61.5M Buy
981,440
+66,760
+7% +$4.3M 0.12% 186
2013
Q2 		$57.1M Buy
+914,680
New +$58.1M 0.12% 186

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Waddell & Reed Financial's GSK Position: Q1 2021 in Review

Waddell & Reed Financial reduced its GSK (GSK) stake by 41% in Q1 2021, selling an estimated $39.1M and leaving 1,216,636 shares worth $54.3M. The position accounts for 0.11% of the portfolio, ranked #217.

Waddell & Reed Financial first reported a position in GSK in Q2 2013 and has held it in 18 quarters since. The position peaked at $266M in Q4 2014. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Waddell & Reed Financial held 1,216,636 shares of GSK worth $54.3M as of Q1 2021.
  • Waddell & Reed Financial sold 861,664 GSK shares in Q1 2021, an estimated $39.1M.
  • GSK made up 0.11% of Waddell & Reed Financial's portfolio in Q1 2021, its #217 holding.
  • Waddell & Reed Financial first reported a position in GSK in Q2 2013 and has held it in 18 quarters since.
  • Waddell & Reed Financial's GSK position peaked at $266M in Q4 2014.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.